Table I.
Clinical and biochemical characteristics of diabetic and non-diabetic hemodialysis patients
| Parameter | HD DM (+) (n = 19) | HD DM (–) (n = 41) |
|---|---|---|
| Age [years] | 69.33 ±10.94 | 57.60 ±16.66*** |
| Dialysis vintage [months] | 35.35 ±28.95 | 59.56 ±62.71 |
| Hemoglobin [g/dl] | 10.98 ±1.48 | 11.03 ±1.54 |
| Erythrocyte count [×1012/µl] | 3.60 ±0.57 | 3.64 ±0.48 |
| MCV [fmol] | 95.71 ±7.34 | 94.19 ±6.39 |
| Leukocyte count [×103/µl] | 6.64 ±1.77 | 6.27 ±1.99 |
| Platelet count [×106/µl] | 210.48 ±46.41 | 173.36 ±66.74* |
| Urea pre HD [mg/dl] | 112.57 ±38.28 | 130.07 ±41.90 |
| Kt/V | 1.23 ±0.22 | 1.38 ±0.21* |
| Residual renal function [ml] | 457.14 ±494.79 | 264.17 ±408.23* |
| TSAT [%] | 33.30 ±13.20 | 31.33 ±13.61 |
| Ferritin [ng/ml] | 341.65 ±143.04 | 491.69 ±421.80 |
| Cholesterol [mg/dl] | 172.90 ±34.36 | 170.56 ±37.84 |
| Triglycerides [mg/dl] | 144.30 ±100.56 | 131.27 ±48.66 |
| Fibrinogen [mg/l] | 406.39 ±86.99 | 381.35 ±110.40 |
| Dry weight [kg] | 83.50 ±26.54 | 69.27 ±16.50** |
| Weight gain between HD [kg] | 2.88 ±1.86 | 1.97 ±1.23* |
| BMI [kg/m2] | 29.87 ±4.29 | 25.13 ±5.08* |
| Systolic blood pressure pre HD [mm Hg] | 138.57 ±22.32 | 136.58 ±22.28 |
| Diastolic blood pressure pre HD [mm Hg] | 68.70 ±89.51 | 79.50 ±13.29** |
| Systolic blood pressure post HD [mm Hg] | 123.71 ±34.61 | 125.19 ±26.14 |
| Diastolic blood pressure post HD [mm Hg] | 66.12 ±8.86 | 71.85 ±12.97 |
| ACE inhibitors [%] | 48 | 42 |
| ARB [%] | 10 | 0 |
| β-Blockers [%] | 71 | 58 |
| Calcium channel blockers [%] | 67 | 61 |
| Diuretics [%] | 24 | 22 |
| Renalase [µg/ml] | 25.85 ±9.17 | 28.76 ±6.26 |
| VAP-1 [ng/ml] | 322.69 ±106.74 | 278.95 ±76.69* |
Data given are means ± SD
*
p < 0.05
**
p < 0.01
***
p < 0.001